Important aspects of osteoarthritis therapy during the COVID-19 pandemic
https://doi.org/10.14412/1996-7012-2022-1-108-114
Abstract
Chronic systemic inflammation, which is significantly exacerbated by COVID-19 or in conditions of induced physical inactivity, has a great negative effect on the condition of patients with osteoarthritis (OA). Conversely, diseases associated with chronic inflammation (OA, obesity, hypercholesterolemia, bronchial asthma, diabetes mellitus, chronic kidney disease, deficiency of essential micronutrients, etc.) are the background for a more severe course of coronavirus infection. In patients with this comorbid background, infection with SARS-CoV-2 exacerbates chronic systemic inflammation through activation of the NLRP3 inflammasome with the involvement of toll receptors (TLRs). Inflammasome activation is the central mechanism for the formation of the so-called cytokine storm, which leads to pyroptosis of various cell types and the development of multiple organ pathologies characteristic of COVID-19. In addition, induced physical inactivity (immobilization stress) contributes to the development of sarcopenia and increased pain in OA. The chondroprotectors chondroitin sulfate, glucosamine sulfate, undenatured collagen inhibit TLR and inflammasome activation, inhibit muscle mass loss, and may exhibit a direct antiviral effect (inhibit the replication of the SARS-CoV-2 virus).
Supporting agencies: Publication of this article has been supported by Sotex PharmFirma.
About the Authors
A. M. Lila
V.A. Nasonova Research Institute of Rheumatology; Department of Rheumatology, Russian Medical Academy of Continuing Professional Education
Russian Federation
Russian Federation
2/1, Barrikadnaya street, building 1, Moscow 125993
1, Ostrovitianov Str., Moscow 117998
A. G. Chuchalin
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
1, Ostrovitianov Str., Moscow 117998
I. Yu. Torshin
Institute of Pharmacoinformatics, Federal Research Center «Informatics and Management» of the Russian Academy of Sciences
Russian Federation
Russian Federation
44, Vavilova street, building 2, Moscow119333
O. A. Gromova
Institute of Pharmacoinformatics, Federal Research Center «Informatics and Management» of the Russian Academy of Sciences
Russian Federation
Russian Federation
Olga Alekseevna Gromova
44, Vavilova street, building 2, Moscow119333
References
1. Chuchalin AG, editor. Mikronutrienty protiv koronavirusov [Micronutrients against coronaviruses]. Moscow: GEOTAR-Media; 2020. 112 p.
2. Dell'Isola A, Kiadaliri A, Turkiewicz A, et al. The impact of first and second wave of COVID-19 on knee and hip surgeries in Sweden. J Exp Orthop. 2021 Aug 13;8(1):60. doi: 10.1186/s40634-021-00382-7.
3. Cherry L, Gates L, Culliford D, et al. COVID-19 lockdown disrupts support networks integral to maintaining foot health: a mixed-methods study. J Foot Ankle Res. 2021 Jun 30;14(1):46. doi: 10.1186/s13047-021-00486-4.
4. Mendy A, Apewokin S, Wells AA, Morrow AL. Factors Associated with Hospitalization and Disease Severity in a Racially and Ethnically Diverse Population of COVID-19 Patients. medRxiv. 2020 Jun 27:2020.06.25.20137323. doi: 10.1101/2020.06.25.20137323.
5. Gusev EI, Zakharova IN, redaktory. Vitamin D. Smena paradigm [Vitamin D. Paradigm shift]. 2nd edition. Moscow: GEOTAR-Media; 2021. 736 p.
6. Gromova OA, Torshin IYu. Mikronutrienty i reproduktivnoe zdorov'e. Rukovodstvo [Micronutrients and reproductive health. Guide]. Moscow: GEOTAR-Media; 2019. 672 p.
7. Torshin IYu, Lila AM, Naumov AV, et al. Prospects of personification of prevention and therapy of osteoarthritis based on the analysis of comorbid background, genetic polymorphisms and trace element status. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2021;14(1):28-39. (In Russ.).
8. Lуpez-Reyes A, Martinez-Armenta C, Espinosa-Velбzquez R, et al. NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19. Front Immunol. 2020 Oct 30;11: 570251. doi: 10.3389/fimmu.2020.570251.
9. Roschewski M, Lionakis MS, Sharman JP, et al. Inhibition of Bruton tyrosine kinase in patients with severeCOVID-19. Sci Immunol. 2020 Jun 5;5(48):eabd0110. doi: 10.1126/sciimmunol.abd0110. Epub 2020 Jun 5.
10. Scarsi M, Piantoni S, Colombo E, et al. Association between treatment with colchicine and improved survivalin a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acuterespiratory distress syndrome. Ann Rheum Dis. 2020 Oct;79(10):1286-9. doi: 10.1136/annrheumdis-2020-217712. Epub 2020 Jul 30.
11. McCarty MF, Iloki Assanga SB, Lewis Lujan L, et al. Nutraceutical Strategies for Suppressing NLRP3 Inflammasome Activation: Pertinence to the Management of COVID-19 and Beyond. Nutrients. 2020 Dec 25;13(1):47. doi: 10.3390/nu13010047.
12. Chiu HW, Li LH, Hsieh CY, et al. Glucosamine inhibits IL-1 expression by preserving mitochondrial integrity and disrupting assembly of the NLRP3 inflammasome. Sci Rep. 2019 Apr 3;9(1):5603. doi: 10.1038/s41598-019-42130-z.
13. Torshin IYu, Gromova OA, Lila AM, et al. Toll-like receptors as a part of osteoarthritis pathophysiology: anti-inflammatory, analgesic and neuroprotective effects. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2021;13(4): 123-9. (In Russ.). doi: 10.14412/2074-2711-2021-4-123-129
14. Korotkyi O, Huet A, Dvorshchenko K, et al. Probiotic Composition and Chondroitin Sulfate Regulate ТЛР-2/4-Mediated NF-kB Inflammatory Pathway and Cartilage Metabolism in Experimental Osteoarthritis. Probiotics Antimicrob Proteins. 2021 Aug;13(4):1018-32. doi: 10.1007/s12602-020-09735-7. Epub 2021 Jan 18.
15. Lila AM, Gromova OA. Torshin IYu, et al. Molecular effects of chondroguard in osteoarthritis and herniated discs. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2017;9(3):88–97. (In Russ.). doi: 10.14412/2074-2711-2017-3-88-97
16. Stabler TV, Huang Z, Montell E, et al. Chondroitin sulphate inhibits NF- B activity induced by interaction of pathogenic and damage associated molecules. Osteoarthritis Cartilage. 2017 Jan;25(1):166-74. doi: 10.1016/j.joca.2016.08.012
17. Narici M, Vito G, Franchi M, et al. Impact of sedentarism due to the COVID-19 home confinement on neuromuscular, cardiovascular and metabolic health: Physiological and pathophysiological implications and recommendations for physical and nutritional countermeasures. Eur J Sport Sci. 2021 Apr;21(4): 614-35. doi: 10.1080/17461391.2020.1761076. Epub 2020 May 12.
18. Jakiela JT, Waugh EJ, White DK. Walk At Least 10 Minutes a Day for Adults With Knee Osteoarthritis: Recommendation for Minimal Activity During the COVID-19 Pandemic. J Rheumatol. 2021 Feb;48(2):157-9. doi: 10.3899/jrheum.200914. Epub 2020 Aug 15.
19. Gromova OA, Torshin IYu, Lila AM, et al. Molecular mechanisms of myoprotective action of chondroitin sulfate and glucosamine sulfate in sarcopenia. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(1):117-24. (In Russ.). doi: 10.14412/2074-2711-2019-1-117-124
20. Petersen SG, Beyer N, Hansen M, et al. Nonsteroidal anti-inflammatory drug or glucosamine reduced pain and improved muscle strength with resistance training in a randomized controlled trial of knee osteoarthritis patients. Arch Phys Med Rehabil. 2011 Aug;92(8): 1185-93. doi: 10.1016/j.apmr.2011.03.009.
21. Sarvilina IV. On the effectiveness of the parenteral form of chondroitin sulfate in patients with osteoarthritis with functional joint insufficiency of the 1st degree. Vrach. 2022;33(1): 31-40. (In Russ.).
22. Nasonov EL, Belov BS, Lila AM, et al. The course and outcomes of COVID-19 in patients with immuno-inflammatory rheumatic diseases: preliminary data from the COVID-19 NIIR/ARR register and literature review. Nauchno-prakticheskaya revmatologiya. 2021;59(6): 666–75. (In Russ.).
23. Carfi A, Bernabei R, Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020 Aug 11;324(6):603-5. doi: 10.1001/jama.2020.12603.
24. Bakilan F, Gokmen IG, Ortanca B, et al. Musculoskeletal symptoms and related factors in postacute COVID-19 patients. Int J Clin Pract. 2021 Nov;75(11):e14734. doi: 10.1111/ijcp.14734. Epub 2021 Aug 18.
25. Endstrasser F, Braito M, Linser M, et al. The negative impact of the COVID-19 lockdown on pain and physical function in patients with end-stage hip or knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2020 Aug;28(8):2435-43. doi: 10.1007/s00167-020-06104-3. Epub 2020 Jun 18.
26. Alhassan E, Siaton BC, Hochberg MC. Did COVID-19 impact osteoarthritis – clinical perspective? Curr Opin Rheumatol. 2022 Jan 1;34(1):68-72. doi: 10.1097/BOR.0000000000000851.
27. Gromova OA, Torshin IYu, Lila AM, Gromov AN. Molecular mechanisms of action of glucosamine sulfate in the treatment of degenerative- dystrophic diseases of the joints and spine: results of proteomic analysis. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(2):38-44. (In Russ.). doi: 10.14412/2074-2711-2018-2-38-44
28. Damlar I, Esen E, Tatli U. Effects of glucosamine-chondroitin combination on synovial fluid ИЛ-1beta, ИЛ-6, TNF-alpha and PGE2 levels in internal derangements of temporomandibular joint. Med Oral Patol Oral Cir Bucal. 2015;20(3):e278-e283.
29. Torshin IYu, Lila AM, Naumov AV, et al. Meta-analysis of clinical studies of the effectiveness of osteoarthritis treatment with Chondrogard. FARMAKOEKONOMIKA. Sovremennaya Farmakoekonomika i Farmakoepidemiologiya. 2020;13(4):18-29. (In Russ.).
30. Wang H. A Review of the Effects of Collagen Treatment in Clinical Studies.Polymers (Basel). 2021 Nov 9;13(22):3868. doi: 10.3390/polym13223868. PMID: 34833168
31. Torshin IYu, Gromova OA, Chuchalin AG, Zhuravlev YuI. Chemoreactomic screening of the effects of pharmacological drugs on SARSCoV- 2 and human virom as an information basis for decision-making on COVID-19 pharmacotherapy. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2021;14(2):191-211. (In Russ.).
32. Gromova OA, Torshin IYu, Chuchalin AG, Maksimov VA. Microbiome, probiotics and COVID-19: promising approaches to support innate and acquired immunity systems. Eksperimental'naya i klinicheskaya gastroenterologiya. 2021;188(4):66-73. (In Russ.).
33. Gromova OA, Torshin IYu, Naumov AV, Maksimov VA. Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and nonsteroidal anti-inflammatory drugs. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2020;13(3):270-82. (In Russ.).
34. Torshin IYu, Lila AM, Gromova OA. Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2021;14(4):515-25. (In Russ.).
35. Torshin IYu, Lila AM, Limanova OA, Gromova OA. Prospects for the use of chondroitin sulfate and glucosamine sulfate in osteoarthritis in combination with pathology of the kidneys and urinary system. FARMAKOEKONOMIKA. Sovremennaya Farmakoekonomika i Farmakoepidemiologiya. 2020;13(1):23-34. (In Russ.).
Review
For citations:
Lila AM, Chuchalin AG, Torshin IY, Gromova OA. Important aspects of osteoarthritis therapy during the COVID-19 pandemic. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2022;16(1):108-114. (In Russ.) https://doi.org/10.14412/1996-7012-2022-1-108-114
Views:
650
Email this article 